Skip directly to page options Skip directly to A-Z link
Volume 25, Number 12—December 2019
Synopsis

Global Epidemiology of Buruli Ulcer, 2010–2017, and Analysis of 2014 WHO Programmatic Targets

Till F. OmansenComments to Author , Alfred Erbowor-Becksen, Rie Yotsu, Tjip S. van der Werf, Alexander Tiendrebeogo, Lise Grout, and Kingsley Asiedu
Author affiliations: Bernhard Nocht Institute for Tropical Medicine and University Medical Center Hamburg-Eppendorf, Hamburg, Germany (T.F. Omansen); World Health Organization, Geneva, Switzerland (T.F. Omansen, A. Erbowor-Becksen, L. Grout, K. Asiedu); Indiana University, Indianapolis, Indiana, USA (A. Erbowor-Becksen); Nagasaki University, Nagasaki, Japan (R. Yotsu); National Center for Global Health and Medicine, Tokyo, Japan (R. Yotsu); University of Groningen, Groningen, the Netherlands (T.S. van der Werf); World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo (A. Tiendrebeogo)

Main Article

Table 1

Overview of status on WHO 2014 programmatic targets for Buruli ulcer*

WHO programmatic targets 2012 data Target set in 2013 2014 data 2017 data
1. PCR confirmation 50% ≥70% 64% 58%
2. Category III lesions 33% <25% 37% 31%
3. Ulcerative lesions 84% ≤60% 64% 75%
4. Movement limitation 25% ≤15% 15% 17%

*Targets were formulated at the 2013 WHO Buruli Ulcer Research and Control Meeting (26). Targets were based on the average of data reported from countries in 2012. They were set to be achieved by the end of 2014. Values represent means weighted for case burden of every country, computed from data reported to WHO. For some countries, information on a certain indicator was not available, if this was the case, the case burden was exempted from the calculation for this specific indicator. Red shading indicates failure to meet target; green shading indicates that the target was met. WHO, World Health Organization.

Main Article

Page created: November 18, 2019
Page updated: November 18, 2019
Page reviewed: November 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external